Skip to main content

Advertisement

Table 2 Clinical characteristics of the study population and comparative effectiveness of FPT in LPN

From: New high intensity fibreoptic phototherapy devices in healthy newborns: a single pad wrapped around the neonate body in comparison with a double pad device

  LPN group 1(57) LPN group 2 (9) P
Gestational age (wks) 35.1 ± 0.8 35.8 ± 0.4 0.02
Birthweight (g) 2657 ± 481 2603 ± 256 0.74
Gender (male) 26 (45.6) 5 (55.5) 0.58
AB0 mismatch 8 (14.0) 1 (11.1) 0.81
Rh mismatch 3 (5.3) 1 (11.1) 0.49
Cesarean section 15 (26.3) 0 0.09
Apgar score at 5’ 9.2 ± 0.7 9.3 ± 0.5 0.59
SGA 2 (3.5) 1 (11.1) 0.31
Age at FPT start (h) 49 ± 17 55 ± 12 0.33
TSB at FPT start (mg/dl) 12.6 ± 2.0 13.6 ± 1.2 0.17
TSB at FPT stop (mg/dl) 8.9 ± 2.0 10.7 ± 1.5 0.01
FPT duration (h) 50.5 ± 18.4 50.9 ± 23.2 0.95
TSB reduction at stop of FPT (%) 28.9 ± 14.5 20.0 ± 16.0 0.10
TSB hourly reduction in PT (mg/dl/h) 0.08 ± 0.06 0.07 ± 0.07 0.65
TSB maximum rebound (%) 24.4 ± 20.2 28.0 ± 15.0 0.61
Check numbers after discharge 1.9 ± 1.2 2.2 ± 1.6 0.51
Birthweight variation (%) 3.7 ± 3.2 2.9 ± 1.9 0.47
Weight variation during phototherapy (%) −0.2 ± 2.4 −0.8 ± 1.1 0.46
TSB reduction after 24 h of FPT (%) 15.0 ± 9.0 13.0 ± 11.0 0.55
  1. Data are expressed as mean ± SD or n. (%)